A health hackathon inspired a Stanford dermatology resident to pursue a project to make it easier to monitor patients with chronic skin conditions.
Nicole Martinez, a postdoctoral fellow in biomedical ethics, shares her experiences in the realms of teaching, law, and health in this In the Spotlight Q&A.
A new algorithm helps turn veterinary notes into systemic codes, a development that could help track disease and enable drug trials.
In this piece, Dean Lloyd Minor argues that doctors and researchers have a responsibility to educate people about the role and value of science.
Stanford researchers have shown in rats that pharmacologically active amounts of a fast-acting anesthetic drug could be released from nanoparticle "cages" in small, specified brain areas at which the scientists had aimed a beam of focused ultrasound. In principle, the same approach could work for many drugs with widely differing pharmacological actions and psychiatric applications, and even for some chemotherapeutic drugs used to combat cancer.
During a recent lecture on campus, Stanford neurosurgeon John Adler discussed his entrepreneurial journey.
Geneticist Michael Snyder has tracked the expression of his genes for three years, focusing on changes in response to chronic or acute disease.
A team of Stanford researchers has designed a new flexible "micropillar" electrode to study the behavior of heart cells without affecting their behavior.
A team of Stanford Biodesign innovators has developed a video to increase awareness in India of a serious heart condition, RHD.
In this radio show, Stanford bioethicist David Magnus and host Russ Altman discuss the ethical implications of using AI in health care.
Stanford researchers found that people who underwent a virtual reality experience, called “Becoming Homeless,” were more empathetic toward the homeless.
Health care innovators should take a needs-driven approach, writes Paul Yock, founder of the Stanford Byers Center for Biodesign.
A conversation with reporter-journalist John Carreyrou on his bestselling book about the company Theranos.
Stanford engineer Ellen Kuhl is using computer modeling to provide insight into the progress of neurodegenerative diseases like Alzheimer's.
At a recent conversation hosted by Dean Lloyd Minor, journalist and entrepreneur Jessica Lessin discusses the state of technology and journalism.
A Stanford study examines a key aspect of artificial intelligence: If machines provide advice for patient care, who should those machines be learning from?